In the most recent trading session, MongoDB (MDB) closed at $299.47, indicating a +2.06% shift from the previous trading day.
MongoDB (MDB) closed at $250.83 in the latest trading session, marking a -2.89% move from the prior day.
The market is mispricing MongoDB NASDAQ: MDB, fixating on tepid near-term guidance and the slow acceleration of AI deployment rather than the long-term opportunity. MongoDB's Atlas platform is a winner in real-world AI situations involving profitable scale.
MongoDB (MDB) concluded the recent trading session at $258.11, signifying a -4.24% move from its prior day's close.
In the closing of the recent trading day, MongoDB (MDB) stood at $251.14, denoting a +2.9% move from the preceding trading day.
MongoDB (MDB) reached $225.95 at the closing of the latest trading day, reflecting a -1.54% change compared to its last close.
MongoDB (MDB) is a Zacks Rank #5 (Strong Sell) despite recently beating the Zacks Consensus Estimate. The stock has a Zacks Style Score for Value of f and an A for Growth.
MongoDB stock saw a 30% post-earnings drop, driven by sequential Atlas deceleration and soft forward guidance, as AI is not yet a material driver to revenue growth. Q4 FY26 saw revenue up 26.75% YoY to $695.1M, with non-GAAP operating margin expanding 200 bps and continued upmarket customer growth. Forward guidance for FY27 projects revenue growth of 16–18% and Atlas growth slowing to 22%, tempering near-term expectations.
MongoDB has declined ~40% YTD amid SaaS sector pressure and leadership changes, but now presents a compelling buy opportunity. MDB's non-relational database platform is AI-resistant and mission-critical, with AI serving as a potential tailwind rather than a threat. The company demonstrates strong fundamentals: 20%+ revenue growth, 20%+ pro forma operating margins, and a debt-free balance sheet with $2B+ cash.
MongoDB's Atlas growth outlook signals slowing momentum as consumption trends moderate and enterprise spending stays cautious.
MDB and NOW ride the booming enterprise AI demand, but diverge on growth visibility, monetization pace and near-term outlook dynamics.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?